@Thu, 28 Mar 2024
GSE-CI 3,456.53 4.54(+0.13%)arrow_drop_up
GSE-FI 2,001.47 0.00(0.00%)remove
Market Cap 76,660.15 0.00(0.00%)remove
AADS 0.41 0.00(0.00%)remove
ACCESS 4.45 0.00(0.00%)remove
ADB 5.06 0.00(0.00%)remove
AGA 37.00 0.00(0.00%)remove
ALW 0.10 0.00(0.00%)remove
ASG 8.89 0.00(0.00%)remove
BOPP 21.53 0.00(0.00%)remove
CAL 0.42 0.00(0.00%)remove
CLYD 0.03 0.00(0.00%)remove
CMLT 0.10 0.00(0.00%)remove
CPC 0.02 0.00(0.00%)remove
DASPHARMA 0.38 0.00(0.00%)remove
DIGICUT 0.09 0.00(0.00%)remove
EGH 6.10 0.00(0.00%)remove
EGL 2.39 0.00(0.00%)remove
ETI 0.15 0.00(0.00%)remove
FML 3.20 0.00(0.00%)remove
GCB 3.43 0.00(0.00%)remove
GGBL 4.44 0.00(0.00%)remove
GOIL 1.50 0.00(0.00%)remove
HORDS 0.10 0.00(0.00%)remove
IIL 0.05 0.00(0.00%)remove
MAC 5.38 0.00(0.00%)remove
MMH 0.10 0.00(0.00%)remove
MTNGH 1.58 0.00(0.00%)remove
PBC 0.02 0.00(0.00%)remove
RBGH 0.48 0.00(0.00%)remove
SAMBA 0.55 0.00(0.00%)remove
SCB 19.25 0.00(0.00%)remove
SCBPREF 0.90 0.00(0.00%)remove
SIC 0.24 0.00(0.00%)remove
SOGEGH 1.57 0.00(0.00%)remove
TBL 0.82 0.00(0.00%)remove
TLW 11.92 0.00(0.00%)remove
TOTAL 9.50 0.00(0.00%)remove
UNIL 11.85 0.00(0.00%)remove

Intravenous Infusions Limited (IIL)

0.05
0.00%
0.00
Thu, 28 Mar 2024
Date Rated Time % Ch in Stock % Ch in Index Score (%) Status Rating
Rationale
Date Rated Time % Ch in Stock % Ch in Index Score (%) Status Rating
Rationale
18-Jul-17 6 Months Closed Show

Strict industry competition to stifle corporate growth in the medium short term.

Rated By: ogyem.boakye@yahoo.com